University of California, San Francisco: Brain Neoplasms trials
The registry lists 12 Brain Neoplasms studies with University of California, San Francisco as lead sponsor. 4 are open to participants now and 1 have results posted.
Phase 1 3Phase 2 1No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With MeningiomaRecruitingNCT07418775
- Evaluating Biomarkers of Cognitive Dysfunction in Patients With CancerNot yet recruitingNCT07226466
- Functional Organization of the Superior Temporal Gyrus for Speech PerceptionEnrolling by invitationNCT05435859Not applicable
- The Neural Coding of Speech Across Human LanguagesEnrolling by invitationNCT05014841Not applicable
- Safety Study of Aminolevulinic Acid (ALA) to Enhance Visualization and Resection of Tumors of the BrainTerminatedNCT01116661Phase 2Results posted
- Behavioral Health Evaluation and Intervention Program for Patients Undergoing CraniotomyWithdrawnNCT05789862Not applicable
- Magrolimab in Children and Adults With Recurrent or Progressive Malignant Brain TumorsCompletedNCT05169944Phase 1
- Pilot Study of Safety and Toxicity of Acquiring Hyperpolarized Carbon-13 Imaging in Children With Brain TumorsCompletedNCT02947373Phase 1
- Feasibility And Efficacy Of An iPad-Based Cognitive Rehabilitation Program In Brain Tumor PatientsTerminatedNCT02783495Not applicable
- A Single Arm Study of Neurocognitive Outcomes in Patients With Brain Metastases Managed With Stereotactic Radiosurgery (SRS)TerminatedNCT01821443Not applicable
- Neurocognitive Outcomes In Patients Treated With Radiotherapy For Five Or More Brain MetastasesWithdrawnNCT01731704Not applicable
- Stereotactic Radiosurgery and Erlotinib in Treating Patients With Non-Small Cell Lung Cancer and Brain MetastasesWithdrawnNCT00738335Phase 1